TERRY SMITH: Open Payments
NPI 1508952292 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,246 in 146 payments from 20 companies in 2025. Trend: 2023 $4,160 · 2024 $3,352 · 2025 $3,246
Food & beverage: $3,052Education: $194
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $651 |
| Janssen Biotech, Inc. | 23 | $528 |
| Mallinckrodt Hospital Products Inc. | 15 | $295 |
| ABBVIE INC. | 14 | $270 |
| Novartis Pharmaceuticals Corporation | 18 | $261 |
| UCB, Inc. | 9 | $192 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Radius Health, Inc. | 7 | $144 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $128 |
Products named: TREMFYA, OTEZLA, ACTHAR, COSENTYX, Bimzelx, RINVOQ, SAPHNELO, UPLIZNA.
Industry payments across FL — which companies pay providers there.
